-- 周四盘前交易中，受大量企业财报和经济数据的影响，标普500指数ETF（SPDR S&P 500 ETF Trust，SPY）上涨0.2%，景顺QQQ ETF（QQQ）上涨0.1%。 美国股指期货也走高，标普500指数期货上涨0.1%，道琼斯工业平均指数期货上涨0.1%，纳斯达克指数期货在常规交易开始前均上涨0.1%。 职业咨询公司Challenger, Gray & Christmas周四发布的报告显示，受人工智能应用增加的影响，4月份美国裁员意愿上升，其中科技行业的裁员尤为突出。 截至5月2日当周，美国首次申请失业救济人数升至20万人，高于前一周向上修正后的19万人，低于彭博社汇总的分析师调查预期的20.5万人。 美国劳工统计局公布的数据显示，第一季度非农生产率增长0.8%，高于彭博社截至美东时间上午7:40汇总的调查预期的0.6%。此前第四季度非农生产率增长1.6%，后经向下修正。 2月和3月的建筑支出数据将于美东时间上午10:00公布，随后是每周天然气库存数据，将于美东时间上午10:30公布。 3月份的消费者信贷数据将于美东时间下午3:00公布。 明尼阿波利斯联储主席尼尔·卡什卡利和纽约联储主席约翰·威廉姆斯将于周四发表讲话。 盘前交易中，比特币下跌0.6%。加密货币ETF方面，ProShares比特币策略ETF (BITO)下跌0.8%，以太坊ETF (EETH)下跌1%，比特币和以太坊市值加权ETF (BETH)持平。 重点关注： 工业板块 道富工业精选行业SPDR ETF (XLI)上涨0.3%，先锋工业指数基金 (VIS)持平，iShares美国工业ETF (IYJ) 未成交。 MDA Space (MDA) 股价在开盘前上涨超过8%，此前该公司公布了第一季度调整后盈利和营收均高于预期。 涨跌幅榜： 医疗保健 道富医疗保健精选行业SPDR ETF (XLV)上涨0.1%，先锋医疗保健指数基金 (VHT)下跌0.3%，而iShares美国医疗保健ETF (IYH)下跌1.5%。iShares生物科技ETF (IBB)上涨0.8%。 Viatris (VTRS)股票盘前下跌超过3%，此前收盘上涨2.8%。该公司公布了高于预期的第一季度财务业绩，并重申了其2026年的业绩指引。 金融 道富金融精选行业SPDR ETF (XLF)下跌0.2%。Direxion每日3倍做多金融ETF (FAS)下跌0.4%，而其做空ETF Direxion每日3倍做空金融ETF (FAZ)上涨0.4%。 凯雷集团 (CG) 股价在盘前交易中下跌超过 3%，此前该公司公布的第一季度税后可分配利润和营收均低于预期。 科技板块 道富科技精选行业 SPDR ETF (XLK) 下跌 0.01%，iShares 美国科技 ETF (IYW) 下跌 0.03%，iShares 扩展科技行业 ETF (IGM) 下跌 0.7%。半导体 ETF 方面，道富 SPDR 标普半导体 ETF (XSD) 上涨 0.03%，iShares 半导体 ETF (SOXX) 上涨 0.4%。 Alphabet (GOOG, GOOGL) 股价在盘前交易中上涨超过 2%，此前一交易日收盘上涨 2.8%。彭博社报道称，谷歌已提议更改其搜索引擎中新闻结果的显示方式，以避免欧盟进一步的反垄断罚款。 消费板块 道富消费必需品精选行业SPDR ETF (XLP) 下跌0.3%，先锋消费必需品指数基金ETF (VDC) 上涨0.03%，而iShares美国消费必需品ETF (IYK) 未成交。道富非必需品精选行业SPDR ETF (XLY) 下跌0.7%。VanEck零售ETF (RTH) 上涨0.6%，而道富SPDR标普零售ETF (XRT) 下跌0.3%。 路透社报道称，特斯拉(TSLA)在中国生产的电动汽车销量连续第六个月同比增长，受此消息提振，特斯拉股价盘前上涨超过1%。 能源板块 iShares美国能源ETF (IYE) 下跌0.9%，而道富能源精选行业SPDR ETF (XLE) 下跌1.1%。壳牌公司 (SHEL) 股价在开盘前下跌超过 1%，此前该公司公布的第一季度营收低于预期。 大宗商品 纽约商品交易所 (NYMEX) 近月合约美国西德克萨斯中质原油下跌 3.3%，至每桶 91.97 美元。天然气下跌 1%，至每百万英热单位 (BTU) 2.70 美元。美国石油基金 (USO) 下跌 3.3%，美国天然气基金 (UNG) 下跌 0.3%。 纽约商品交易所 (Comex) 5 月黄金期货上涨 1.2%，至每盎司 4,748.30 美元。白银期货上涨 5.4%，至每盎司 81.44 美元。SPDR 黄金信托 (GLD) 上涨 1%，iShares 白银信托 (SLV) 上涨 4.7%。
Related Articles
Australia
CVS Health Increasingly Likely to Reach 3% Medicare Advantage Target Margin in 2028, RBC Says
CVS Health (CVS) is increasingly more likely to reach its 3% Medicare Advantage target margin in 2028, RBC Capital Markets analyst said in a note Wednesday.Analysts said the company's Q1 adjusted earnings "comfortably" beat expectations, driven by "strong" topline growth and a notable improvement in profitability in the Health Care Benefits segment.Medical costs came in below expectations and, while the company maintained its medical benefit ratio guidance for the year, it is increasingly likely to outperform, according to the note.The brokerage raised its 2026 adjusted earnings estimate for the company to $7.41 from $7.10. Analysts surveyed by FactSet expect $7.29.RBC reiterated its outperform rating on the stock and increased its price target to $107 from $93.Price: $87.01, Change: $+0.14, Percent Change: +0.17%
$CVS
Research
Research Alert: CFRA Maintains Strong Buy Rating On Shares Of Trimble Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our target price to $86, from 85, on a forward P/E of 21x our 2027 EPS projection of $4.08, below historical averages. We increase our 2026 EPS projection to $3.59 from $3.52, and lift our 2027 EPS estimate to $4.08 from $4.06. TRMB reported solid Q1 beats with revenue of $939.9M, up 12% Y/Y, led by AECO at 14% organic revenue and ARR growth, Field Systems posting 12% growth, and Transportation & Logistics growing 7% despite freight market headwinds. ARR reached a record $2.435B, up 13% organically, reinforcing business model durability. Non-GAAP operating margin improved 230 bps to 25.9%, while non-GAAP gross margins expanded 180 bps to 71.0%, and we see continued margin expansion as its subscription revenues scale. We note steady execution in its core business, while building AI momentum through new products and partnerships with AI labs. Management reaffirmed its 2027 targets, supporting our positive view, though macro risks warrant monitoring.
$TRMB
Australia
Apollo Global Trades at Lower Discount Versus Peers, RBC Says
Apollo Global Management (APO) shares are trading in-line with historical average multiple and at a lower discount against its peers, RBC Capital Markets said in a Thursday note."We maintain our Sector Perform rating largely driven by relative valuation," the report said.The note said its Q1 performance was characterized by strong fee-related earnings growth, offset by weak spread-related earnings growth, driving a low adjusted net income per share growth.RBC raised its price target to $146 from $139 on rolling forward its valuation and higher estimates.Price: $127.33, Change: $-2.20, Percent Change: -1.70%
$APO